To include your compound in the COVID-19 Resource Center, submit it here.

Cardiovascular

INDICATION: Cardiovascular

In vitro studies identified a peptide inhibitor of PCSK9 that could help reduce the risk

Read the full 168 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE